1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 04732087 2023-04-01 2024-03-31 04732087 2024-03-31 04732087 2023-03-31 04732087 2022-04-01 2023-03-31 04732087 2023-03-31 04732087 2022-03-31 04732087 core:FurnitureFittings 2023-04-01 2024-03-31 04732087 bus:Director1 2023-04-01 2024-03-31 04732087 core:FurnitureFittings 2023-03-31 04732087 core:FurnitureFittings 2024-03-31 04732087 core:WithinOneYear 2024-03-31 04732087 core:WithinOneYear 2023-03-31 04732087 core:ShareCapital 2024-03-31 04732087 core:ShareCapital 2023-03-31 04732087 core:RetainedEarningsAccumulatedLosses 2024-03-31 04732087 core:RetainedEarningsAccumulatedLosses 2023-03-31 04732087 core:FurnitureFittings 2023-03-31 04732087 bus:Director1 2023-03-31 04732087 bus:Director1 2024-03-31 04732087 bus:Director1 2022-03-31 04732087 bus:Director1 2023-03-31 04732087 bus:Director1 2022-04-01 2023-03-31 04732087 bus:SmallEntities 2023-04-01 2024-03-31 04732087 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 04732087 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 04732087 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 04732087 bus:FullAccounts 2023-04-01 2024-03-31 04732087 core:OfficeEquipment 2023-04-01 2024-03-31 04732087 core:OfficeEquipment 2023-03-31 04732087 core:OfficeEquipment 2024-03-31
COMPANY REGISTRATION NUMBER: 04732087
Pharm-AC (UK) Limited
Filleted Unaudited Financial Statements
31 March 2024
Pharm-AC (UK) Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
£
Fixed assets
Tangible assets
5
3,393
4,313
Current assets
Debtors
6
13,504
3,326
Cash at bank and in hand
561
11,376
--------
--------
14,065
14,702
Creditors: amounts falling due within one year
7
14,667
15,528
--------
--------
Net current liabilities
602
826
-------
-------
Total assets less current liabilities
2,791
3,487
-------
-------
Net assets
2,791
3,487
-------
-------
Capital and reserves
Called up share capital
100
100
Profit and loss account
2,691
3,387
-------
-------
Shareholders funds
2,791
3,487
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 10 August 2024 , and are signed on behalf of the board by:
Mr G Panniers
Director
Company registration number: 04732087
Pharm-AC (UK) Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 Minton Place, Victoria Road, Bicester, Oxon, OX26 6QB.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102 .
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures & Fittings
-
25% reducing balance
Office Equipment
-
25% reducing balance
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Tangible assets
Fixtures and fittings
Equipment
Total
£
£
£
Cost
At 1 April 2023
5,691
26,751
32,442
Additions
1,393
1,393
Disposals
( 5,336)
( 22,097)
( 27,433)
-------
--------
--------
At 31 March 2024
355
6,047
6,402
-------
--------
--------
Depreciation
At 1 April 2023
5,184
22,945
28,129
Charge for the year
61
659
720
Disposals
( 5,073)
( 20,767)
( 25,840)
-------
--------
--------
At 31 March 2024
172
2,837
3,009
-------
--------
--------
Carrying amount
At 31 March 2024
183
3,210
3,393
-------
--------
--------
At 31 March 2023
507
3,806
4,313
-------
--------
--------
6. Debtors
2024
2023
£
£
Trade debtors
8,403
3,326
Other debtors
5,101
--------
-------
13,504
3,326
--------
-------
7. Creditors: amounts falling due within one year
2024
2023
£
£
Corporation tax
8,969
8,316
Social security and other taxes
4,718
5,249
Other creditors
980
1,963
--------
--------
14,667
15,528
--------
--------
8. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr G Panniers
( 1,073)
60,177
( 54,003)
5,101
-------
--------
--------
-------
2023
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr G Panniers
( 3,193)
43,740
( 41,620)
( 1,073)
-------
--------
--------
-------